Filter
602
Filtered Results: 602
Text search:
World
Health
Organization
WHO,
Regional
Office
for
Eastern
Mediterranean
Region
Featured
Recommendations
74
New Publications
121
Language
Document type
No document type
209
Studies & Reports
182
Guidelines
102
Manuals
40
Strategic & Response Plan
36
Situation Updates
11
Fact sheets
9
Training Material
5
Resource Platforms
5
Brochures
1
Infographics
1
Online Courses
1
Countries / Regions
Global
64
Africa
21
Syria
20
Middle East and North Africa
18
Western and Central Europe
15
South–East Asia Region
8
Latin America and the Carribbean
7
Eastern Europe
6
Sudan
6
Somalia
6
Pakistan
6
West and Central Africa
5
Yemen
5
Afghanistan
4
East and Southern Africa
4
Iraq
4
Myanmar / Burma
4
Iran
3
Nigeria
3
Asia
3
Jordan
3
Eastern Europe and Central Asia
3
Lebanon
3
India
3
North Macedonia
2
Thailand
2
Ukraine
2
Turkey
2
Ghana
2
China
2
Saudi Arabia
2
Bangladesh
2
South Africa
2
Ethiopia
2
Libya
2
Nepal
1
Kenya
1
Benin
1
Sierra Leone
1
Cameroon
1
Albania
1
Morocco
1
Qatar
1
Philippines
1
USA
1
Cambodia
1
Venezuela
1
Croatia
1
Tanzania
1
Western Pacific Region
1
Paraguay
1
Tunisia
1
Uganda
1
Russia
1
Djibouti
1
Egypt
1
Greece
1
Palestine
1
Georgia
1
South Sudan
1
Liberia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
88
Countries
84
Public Health
67
Women & Child Health
53
Key Resources
39
Capacity Building
15
Pharmacy & Technologies
8
Toolboxes
Mental Health
61
COVID-19
60
Rapid Response
39
Planetary Health
39
NTDs
35
TB
34
HIV
32
Refugee
27
AMR
26
Global Health Education
24
Caregiver
21
NCDs
21
Conflict
21
Disability
15
Pharmacy
14
Polio
9
Malaria
8
Cholera
6
Zika
6
Ebola & Marburg
5
Health Financing Toolbox
4
Natural Hazards
3
Specific Hazards
2
Social Ethics
1
10–11 May 2016, Catania, Italy
WHO’s total revenue in 2020 was US$ 4299 million and total expenses were US$ 3561 million, resulting in a surplus of US$ 824 million, which includes finance revenue (e.g. interest and investment income) of US$ 86 million, representing increases of 38% and 15% in revenue and expenses respectively. ...
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...
WHO Recommendations 2018 Update
The primary audience for these recommendations includes health professionals who are responsible for developing national and local health care guidelines and protocols (particularly those related to PPH prevention and treatment) and those involved in the provision of...
Objectives and scope of the document
This document was developed to provide recommended management strategies for problems and disorders that are specifically related to the occurrence of a major stressful event. The recommended strategies will form the basis of a new module to be added to the WHO ...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
School health programmes are the most cost-effective way to influence health behaviours in young people. The purpose of this two-part handbook is to support schools as they seek to implement interventions in order to reduce the main modifiable risk behaviours for noncommunicable disea...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Cholera is a major health risk in many parts of the world, affecting millions of people every year. Since mid-2021, the world has been facing an acute upsurge of the 7th cholera pandemic, which is characterized by the number, size and concurrence of multiple outbreaks, the spread to areas that had b...
The road map sets global targets and milestones to prevent, control, eliminate or eradicate 20 diseases and disease groups as well as cross-cutting targets aligned with the Sustainable Development Goals. Three foundational pillars will support global efforts to achieve the targets: accelerate progra...
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
During the past five decades, the incidence of dengue has increased 30-fold. Some 50–100 million new infections are estimated to occur annually in more than 100 endemic countries, with a documented further spread to previously unaffected areas; every year hundreds of thousands of severe cases ari...
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t...
These guidelines provide a recommendation on iodine thyroid blocking (ITB), via oral administration of stable iodine, as an urgent protective action in responding to a nuclear accident. This recommendation aims to support emergency planners, policy makers, public health specialists, clinicians and o...
Interim guidanceAnnex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021
9 March 2022, Timely and accurate diagnostic testing for SARS-CoV-2 is an essential part of a comprehensive COVID-19 response strategy. Ag-RDTs can be performed by individuals in which they collect their own specimen, perform a simple rapid test and interpret their test result themselves at a time a...
